AM

Ankitkumar Mukeshkumar Patel

Active Director Designated Partner DIN 11835122
DIN 11835122 First appointment Jul 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Ankitkumar Mukeshkumar Patel

Ankitkumar Mukeshkumar Patel is a Designated Partner at Nsb Pharma Machinery Llp (since 2026).

DIN 11835122
Primary Designation Designated Partner
First Appointment 17 Jul 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner17 Jul 20262026Active

Board colleagues of Ankitkumar Mukeshkumar Patel

NameDINCompanyDesignation
Nilesh Shantilal Bhardiya10378140Nsb Pharma Machinery LlpDesignated Partner
Vinayakkumar Arvindbhai Vasoya11835121Nsb Pharma Machinery LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Nsb Pharma Machinery Llp
Premium access

Shareholding and investment profile for Ankitkumar Mukeshkumar Patel

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Ankitkumar Mukeshkumar Patel

Ankitkumar Mukeshkumar Patel currently holds 1 directorship: Nsb Pharma Machinery Llp (Designated Partner, since 17 Jul 2026).

Ankitkumar Mukeshkumar Patel was first appointed on 17 Jul 2026 as Designated Partner at Nsb Pharma Machinery Llp.

The current boards of Ankitkumar Mukeshkumar Patel's companies include Nilesh Shantilal Bhardiya (Nsb Pharma Machinery Llp), Vinayakkumar Arvindbhai Vasoya (Nsb Pharma Machinery Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available